This diagnostic is powered by noninvasive measurements of host-derived protease activity, a means of pneumonia classification distinct from the oft-cited biomarkers such as CRP, PCT, and inflammatory cytokines. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.